Integraton between oncology and palliatve care: A plan for the next decade?

Tumori

Volumn 103, Issue 1, 2017, Pages 1-8

  Kaasa, Stein ^a,b,c   Knudsen, Anne Kari ^a,b,c   Lundeby, Tonje ^a,b,c   Loge, Jon Håvard ^a,b,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

End of life care; Futle treatment; Integraton; Oncology; Palliatve care; Research collaboraton

Indexed keywords

CANCER THERAPY; COMMUNITY CARE; FAMILY; HEALTH CARE QUALITY; HOSPITAL; HUMAN; MODEL; ONCOLOGY; PATENT; QUALITY OF LIFE; SYMPTOM; TERMINAL CARE; INTEGRATED HEALTH CARE SYSTEM; NEOPLASMS; ORGANIZATION AND MANAGEMENT; PALLIATIVE THERAPY; PATHOPHYSIOLOGY;

DELIVERY OF HEALTH CARE, INTEGRATED; FAMILY; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PALLIATIVE CARE; QUALITY OF LIFE;

EID: 85012009143     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.5301/tj.5000602     Document Type: Review

References (42)

1. Høst H. Postoperatve radiotherapy in breast cancer. Experienta Suppl. 1982; 41: 580-586.
2. DeVita VT, Canellos GP. Combinaton chemotherapy of solid tumors: an American-Italian collaboraton: a celebraton of the work of Gianni Bonadonna. Tumori. 2016; 102(2): 124-126.
3. Bonadonna G, Rossi A, Valagussa P. Adjuvant CMF chemotherapy in operable breast cancer: ten years later. Lancet. 1985; 1(8435): 976-977.
4. Bonadonna G, Valagussa P. Adjuvant systemic therapy for resectable breast cancer. J Clin Oncol. 1985; 3(2): 259-275.
5. Veronesi U, Zucali R, Luini A. Local control and survival in early breast cancer: the Milan trial. Int J Radiat Oncol Biol Phys. 1986; 12(5): 717-720.
6. WHO's cancer pain ladder for adults: www.who.int. Available from: http://www.who.int/cancer/palliatve/painladder/en. Accessed December 14, 2016.
7. Cancer Pain Relief WHO Geneva 1986: World Health Organizaton www.who.int; 1986. Available from: http://apps.who.int/iris/bitstream/10665/43944/1/9241561009-eng.pdf. Accessed December 14, 2016.
8. Dame Cicely Saunders - Her life and work www.stchristophers.org.uk. Available from: http://www.stchristophers.org.uk/about/damecicelysaunders. Accessed December 14, 2016.
9. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality paterns in Europe: estmates for 40 countries in 2012. Eur J Cancer. 2013; 49(6): 1374-1403.
10. Factsheet WHO. 297 - Cancer www.who.int 2015. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/. Accessed December 14, 2016.
11. Cancer in Norway 2015 - Cancer incidence, mortality, survival and prevalence in Norway.: www.kreftregisteret.no. Available from: https://www.kreftregisteret.no/Generelt/Publikasjoner/Cancer-in-Norway/cancer-in-norway-2015/. Accessed December 14, 2016.
12. World Health Organizaton http://www.who.int [Available from: http://www.who.int/cancer/palliatve/definiton/en/. Accessed December 14, 2016.
13. U.S. Department of Health and Human Services FDA Center for Drug Evaluaton and Research ea. Guidance for industry: patent-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006; 79.
14. Rogg L, Aasland OG, Graugaard PK, Loge JH. Direct communicaton, the unquestonable ideal? Oncologists accounts of communicaton of bleak prognoses. Psychooncology. 2010; 19(11): 1221-1228.
15. Smith TJ, Temin S, Alesi ER, et al. American Society of Clinical Oncology provisional clinical opinion: the integraton of palliatve care into standard oncology care. J Clin Oncol. 2012; 30(8): 880-887.
16. Ferrell BR, Temel JS, Temin S, et al. Integraton of Palliatve Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practce Guideline Update. J Clin Oncol. 2016: 2017; 35(1): 96-112.
17. Schnipper LE, Smith TJ, Raghavan D, et al. American Society of Clinical Oncology identfies five key opportunites to improve care and reduce costs: the top five list for oncology. J Clin Oncol. 2012; 30(14): 1715-1724.
18. Rochigneux P, Raoul JL, Beaussant Y, et al. Use of chemotherapy near the end of life for solid cancers: What factors mater? Ann Oncol. 2016 Dec 19. pii: mdw654. [Epub ahead of print].
19. Pirl WF, Greer JA, Traeger L, et al. Depression and survival in metastatc non-small-cell lung cancer: effects of early palliatve care. J Clin Oncol. 2012; 30(12): 1310-1315.
20. Seow H, Snyder CF, Shugarman LR, et al. Developing quality indicators for cancer end-of-life care: proceedings from a natonal symposium. Cancer. 2009; 115(17): 3820-3829.
21. Wright AA, Zhang B, Ray A, et al. Associatons between end-of-life discussions, patent mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008; 300(14): 1665-1673.
22. Kavalieratos D, Corbelli J, Zhang D, et al. Associaton between palliatve care and patent and caregiver outcomes: a systematic review and meta-analysis. JAMA. 2016; 316(20): 2104-2114.
23. Temel JS, Greer JA, Muzikansky A, et al. Early palliatve care for patents with metastatc non-small-cell lung cancer. N Engl J Med. 2010; 363(8): 733-742.
24. Jordhøy MS, Fayers P, Saltnes T, Ahlner-Elmqvist M, Jannert M, Kaasa S. A palliatve-care interventon and death at home: a cluster randomised trial. Lancet. 2000; 356(9233): 888-893.
25. Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliatve care for patents with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014; 383(9930): 1721-1730.
26. Hjermstad M, Aass N, Aielli F, et al. Characteristcs of the case mix, organisaton and delivery in cancer palliatve care: a challenge for good-quality research. BMJ supportve & palliatve care. 2016: bmjspcare-2015-000997.
27. Jordhøy MS, Fayers P, Loge JH, Ahlner-Elmqvist M, Kaasa S. Quality of life in palliatve cancer care: results from a cluster randomized trial. J Clin Oncol. 2001; 19(18): 3884-3894.
28. De Conno F, Caraceni A, Groff L, et al. Effect of home care on the place of death of advanced cancer patents. Eur J Cancer. 1996; 32A(7): 1142-1147.
29. Ventafridda V, De Conno F, Viganò A, Ripamont C, Gallucci M, Gamba A. Comparison of home and hospital care of advanced cancer patents. Tumori. 1989; 75(6): 619-625.
30. Kaasa S, Jordhøy MS, Haugen DF. Palliatve care in Norway: a natonal public health model. J Pain Symptom Manage. 2007; 33(5): 599-604.
31. Nasjonalt handlingsprogram for palliasjon i kreftomsorgen: helsedirektoratet.no; 2015. Available from: https://helsedirektoratet.no/Lists/Publikasjoner/Atachments/918/Nasjonalt%20handlingsprogram%20for%20palliasjon%20i%20kreftomsorgen-IS-2285.pdf. Accessed December 14, 2016.
32. Together against cancer: Government.no; 2013. Available from: https://www.regjeringen.no/en/dokumenter/together-against-cancer/id728818/?q=together-against-cancer. Accessed December 14, 2016.
33. Nordic Specialist Course in Palliatve Medicine. http://nscpm.org. Accessed December 14, 2016.
34. Helsedirektoratet.no. Palliatv medisin som kompetanseområde 2016. Available from: https://helsedirektoratet.no/autorisasjon-utdanning-og-godkjenning/palliatv-medisin-somkompetanseomrade-. Accessed December 14, 2016.
35. PRC - European Palliatve Care Research Centre https://www.ntnu.edu. Available from: https://www.ntnu.edu/prc. Accessed December 14, 2016.
36. Knudsen A. Improving Care. PEN: Government Issue. 2014(11): 192-3.
37. Sundstrøm S, Bremnes R, Aasebø U, et al. Hypofractonated palliatve radiotherapy (17 Gy per two fractons) in advanced non-small-cell lung carcinoma is comparable to standard fractonaton for symptom control and survival: a natonal phase III trial. J Clin Oncol. 2004; 22(5): 801-810.
38. Kaasa S, Brenne E, Lund J-A, et al. Prospectve randomised multcenter trial on single fracton radiotherapy (8 Gy × 1) versus multple fractons (3 Gy × 10) in the treatment of painful bone metastases. Radiother Oncol. 2006; 79(3): 278-284.
39. Thronæs M, Popper L, Eeg M, Jaatun E, Kvitberg M, Kaasa S. Efficacy and tolerability of intranasal fentanyl spray in cancer patents with breakthrough pain. Clin Ther. 2015; 37(3): 585-596.
40. European Pathway Associaton. http://e-p-a.org/. Available from: http://e-p-a.org/. Accessed December 14, 2016.
41. The Orkdal Model. Collaboraton Between Specialist and Community Care Within Palliatve Cancer Care Clinicaltrials.gov. Available from: https://clinicaltrials.gov/ct2/results?term=NCT02170168. Accessed December 14, 2016.
42. Cherny N, Fallon M, Kaasa S, Portenoy RK, Currow DC. Quality of life in palliatve care: principles and practce. Oxford textbook of palliatve medicine: Oxford University Press, USA; 2015. 1198-209.